145 related articles for article (PubMed ID: 36891734)
1. The oncogenetic landscape and clinical impact of
Dourthe ME; Andrieu GP; Potier A; Balducci E; Guerder J; Simonin M; Courtois L; Petit A; Macintyre E; Boissel N; Baruchel A; Asnafi V
Haematologica; 2023 Nov; 108(11):3165-3169. PubMed ID: 36891734
[No Abstract] [Full Text] [Related]
2. BCL11B promotes T-cell acute lymphoblastic leukaemia cell survival via the XRCC5/C11ORF21 axis.
Yu X; Li Y; Yang P; Wang Y; Liu X; Cai L; Lai J; Zhang Y; Zha X; Przybylski GK; Xu L; Li Y
Clin Transl Med; 2024 Feb; 14(2):e1580. PubMed ID: 38317587
[No Abstract] [Full Text] [Related]
3. Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients.
Bartram I; Gökbuget N; Schlee C; Heesch S; Fransecky L; Schwartz S; Stuhlmann R; Schäfer-Eckhart K; Starck M; Reichle A; Hoelzer D; Baldus CD; Neumann M
J Hematol Oncol; 2014 Jul; 7():51. PubMed ID: 25023966
[TBL] [Abstract][Full Text] [Related]
4. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia.
Gutierrez A; Kentsis A; Sanda T; Holmfeldt L; Chen SC; Zhang J; Protopopov A; Chin L; Dahlberg SE; Neuberg DS; Silverman LB; Winter SS; Hunger SP; Sallan SE; Zha S; Alt FW; Downing JR; Mullighan CG; Look AT
Blood; 2011 Oct; 118(15):4169-73. PubMed ID: 21878675
[TBL] [Abstract][Full Text] [Related]
5. The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation.
Ha VL; Luong A; Li F; Casero D; Malvar J; Kim YM; Bhatia R; Crooks GM; Parekh C
Leukemia; 2017 Nov; 31(11):2503-2514. PubMed ID: 28232744
[TBL] [Abstract][Full Text] [Related]
6. BCL11B, FLT3, NOTCH1 and FBXW7 mutation status in T-cell acute lymphoblastic leukemia patients.
Kraszewska MD; Dawidowska M; Kosmalska M; Sędek L; Grzeszczak W; Kowalczyk JR; Szczepański T; Witt M;
Blood Cells Mol Dis; 2013 Jan; 50(1):33-8. PubMed ID: 23040356
[TBL] [Abstract][Full Text] [Related]
7. B-cell lymphoma/leukaemia 11B (BCL11B) expression status helps distinguish early T-cell precursor acute lymphoblastic leukaemia/lymphoma (ETP-ALL/LBL) from other subtypes of T-cell ALL/LBL.
Fang H; Wang W; El Hussein S; Morita K; Beird HC; Mitra A; Loghavi S; Lin P; Jabbour EJ; Khoury JD
Br J Haematol; 2021 Sep; 194(6):1034-1038. PubMed ID: 34402058
[TBL] [Abstract][Full Text] [Related]
8. Downregulated miR-17, miR-29c, miR-92a and miR-214 may be related to BCL11B overexpression in T cell acute lymphoblastic leukemia.
He Z; Liao Z; Chen S; Li B; Yu Z; Luo G; Yang L; Zeng C; Li Y
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e259-e265. PubMed ID: 29749698
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the expression pattern of the BCL11B gene and its relatives in patients with T-cell acute lymphoblastic leukemia.
Huang X; Chen S; Shen Q; Yang L; Li B; Zhong L; Geng S; Du X; Li Y
J Hematol Oncol; 2010 Nov; 3(1):44. PubMed ID: 21080944
[TBL] [Abstract][Full Text] [Related]
10. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C
Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209
[TBL] [Abstract][Full Text] [Related]
11. BCL11B is frequently downregulated in HTLV-1-infected T-cells through Tax-mediated proteasomal degradation.
Permatasari HK; Nakahata S; Ichikawa T; Morishita K
Biochem Biophys Res Commun; 2017 Aug; 490(3):1086-1092. PubMed ID: 28669733
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiles in BCL11B-siRNA treated malignant T cells.
Huang X; Shen Q; Chen S; Chen S; Yang L; Weng J; Du X; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
J Hematol Oncol; 2011 May; 4():23. PubMed ID: 21575156
[TBL] [Abstract][Full Text] [Related]
13. Oncogenetic landscape of T-cell lymphoblastic lymphomas compared to T-cell acute lymphoblastic leukemia.
Bontoux C; Simonin M; Garnier N; Lhermitte L; Touzart A; Andrieu G; Bruneau J; Lengliné E; Plesa A; Boissel N; Baruchel A; Bertrand Y; Molina TJ; Macintyre E; Asnafi V
Mod Pathol; 2022 Sep; 35(9):1227-1235. PubMed ID: 35562412
[TBL] [Abstract][Full Text] [Related]
14. Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma.
Salmerón-Villalobos J; Ramis-Zaldivar JE; Balagué O; Verdú-Amorós J; Celis V; Sábado C; Garrido M; Mato S; Uriz J; Ortega MJ; Gutierrez-Camino A; Sinnett D; Illarregi U; Carron M; Regueiro A; Galera A; Gonzalez-Farré B; Campo E; Garcia N; Colomer D; Astigarraga I; Andrés M; Llavador M; Martin-Guerrero I; Salaverria I
Pediatr Blood Cancer; 2022 Nov; 69(11):e29926. PubMed ID: 36000950
[TBL] [Abstract][Full Text] [Related]
15. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
[TBL] [Abstract][Full Text] [Related]
16. Mutations of PHF6 are associated with mutations of NOTCH1, JAK1 and rearrangement of SET-NUP214 in T-cell acute lymphoblastic leukemia.
Wang Q; Qiu H; Jiang H; Wu L; Dong S; Pan J; Wang W; Ping N; Xia J; Sun A; Wu D; Xue Y; Drexler HG; Macleod RA; Chen S
Haematologica; 2011 Dec; 96(12):1808-14. PubMed ID: 21880637
[TBL] [Abstract][Full Text] [Related]
17. Emerging molecular subtypes and therapies in acute lymphoblastic leukemia.
Davis K; Sheikh T; Aggarwal N
Semin Diagn Pathol; 2023 May; 40(3):202-215. PubMed ID: 37120350
[TBL] [Abstract][Full Text] [Related]
18. [Genetic and epigenetic landscape of pediatric T-cell acute lymphoblastic leukemia].
Kimura S
Rinsho Ketsueki; 2019; 60(5):459-467. PubMed ID: 31168014
[TBL] [Abstract][Full Text] [Related]
19. The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest.
Ben Abdelali R; Asnafi V; Petit A; Micol JB; Callens C; Villarese P; Delabesse E; Reman O; Lepretre S; Cahn JY; Guillerm G; Berthon C; Gardin C; Corront B; Leguay T; Béné MC; Ifrah N; Leverger G; Dombret H; Macintyre E
Haematologica; 2013 Nov; 98(11):1711-7. PubMed ID: 23831922
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic isoform switch of tumor suppressor BCL11B in adult T-cell leukemia/lymphoma.
Permatasari HK; Nakahata S; Ichikawa T; Fauzi YR; Kiyonari H; Shide K; Kameda T; Shimoda K; Ono M; Taki T; Taniwaki M; Futakuchi M; Morishita K
Exp Hematol; 2022 Jul; 111():41-49. PubMed ID: 35421541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
